Nrc Health

This management proposal requests an advisory, non-binding approval of the Company’s executive compensation as disclosed in the proxy statement (CD&A and compensation tables). Management seeks affirmation of its pay practices after significant leadership changes in 2025 and meaningful equity awards to align executives with stockholders. The Board and Compensation Committee frame the program around competitive pay, alignment with stockholders through equity grants, and retention of key executives; they note prior strong shareholder support (approximately 99% approval in 2025). The vote is non-binding but the Board will consider results in future decisions; the recommendation is FOR due to belief that compensation supports strategy, aligns incentives, and was overwhelmingly supported previously. The proposal raises standard governance scrutiny points—magnitude of awards to incoming executives and change-in-control or repurchase restrictions addressed by subsequent amendments—but management argues the grants were necessary to attract/retain leadership and align interests. Given the program's reliance on substantial upfront equity grants and cash bonuses to cover tax obligations, stockholders will assess whether pay-for-performance and retention outcomes justify the awards.

This management proposal would amend Article 6 of the company’s certificate of incorporation to eliminate various supermajority voting thresholds that currently restrict amendments to director-related charter and bylaw provisions, including deleting a requirement that changes receive 66 2/3% stockholder approval and removing a board Requisite Vote requirement. Management seeks shareholder approval to lower these thresholds to majority voting in most instances and to make minor conforming and clarifying edits (including affirming no cumulative voting). The board frames the change as governance modernization following the recent declassification of the board, aligning the charter with common market practice and proxy-advisor expectations to enhance director accountability and stockholder influence. Management acknowledges concentrated ownership by the Hays family entities and considered that declassification paired with reduced supermajority protections creates risk that controlling stockholders could more easily influence board composition; however, the board concluded that majority-vote rules better align all stockholders’ governance rights with economic interests. The board recommends FOR, arguing the changes are pro‑stockholder and prudently follow the declassification. The proposal involves structural governance changes with potential anti‑takeover and control implications, and investors should weigh the tradeoff between enhanced accountability and the potential empowerment of a controlling holder to influence board composition if ownership consolidates further.

This management proposal requests an amendment to the certificate of incorporation to remove existing constraints that limit director removal to 'for cause' in certain circumstances and to allow directors to be removed with or without cause, consistent with the company's recent declassification of the board and Delaware law. The proposed changes also include conforming revisions to vacancy-filling rules to account for the ability to remove directors without cause. Management frames the amendment as a technical and legal alignment that corrects inconsistencies between the charter and the declassified board structure and modernizes governance practice. The board recommends FOR, arguing it creates consistency with the bylaws, provides appropriate flexibility, and reflects the declassification decision. While largely procedural, the change has substantive governance impact by lowering barriers to removing directors and could enable shareholders (including a controlling holder) to effect board turnover more readily; investors should consider implications for board stability and potential influence by large holders.

This management proposal would amend Article 7 of the certificate of incorporation to eliminate the current requirement that written consent by shareholders be unanimous in favor of an action, and instead require only the number of votes that would be necessary to approve the action at a duly convened meeting (typically a majority). Management argues that the unanimous standard is impracticable among a large and publicly traded shareholder base, effectively preventing shareholders from exercising written-consent rights and creating an anti-takeover effect. The proposed change is designed to enhance shareholder ability to act between meetings while aligning with common market practice and proxy-advisor expectations. The Board recommends FOR, emphasizing the balance between enabling shareholder action and preserving corporate stability; however, investors should weigh that lowering the threshold could also make it easier for a concentrated holder to act by written consent, potentially enabling rapid governance changes if ownership consolidates.